Zantac tablet recall
Posted on: 10/15/2019
PNP is aware of a voluntary recall of the tablet form of Zantac (generic is called Ranitidine), which is a medication used to treat heartburn and reflux. The recall comes as the FDA has found an impurity in the Zantac called NDMA. Zantac/Ranitidine is available both via prescription and over-the-counter and not all versions are recalled.
There is no official guidance that patients need to stop Zantac or switch to another medicine, though other medicines in the same class are not being recalled at this time. One example of a similar medicine in the same class is Pepcid, which is also sold over-the-counter.
Some of our youngest patients are on liquid Zantac (Ranitidine) for reflux and at this time, there is no recall of the liquid version. The FDA is testing liquid Zantac will provide more guidance on this in the near future. When we get subsequent updates, we will do our best to continue to update you.
For more information from the best source, here is a link to the FDA's website on the Zantac recall
As always, if you have any questions, please feel free to call our office. Our nurses can help provide guidance and we can always have your pediatrician see your child and re-discuss alternatives.
Yours in good pediatric health,
The Doctors at PNP